Midie Xu
- Molecular Biology top 5%
- Cancer Research top 1%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Surgery
- Topics
- Cancer-related molecular mechanisms research (20 papers)RNA modifications and cancer (19 papers)Ferroptosis and cancer prognosis (18 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Midie Xu
99 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 1.6k
- Cancer Research 1.3k
- Oncology 709
- Pulmonary and Respiratory Medicine 471
- Surgery 244
Countries citing papers authored by Midie Xu
This map shows the geographic impact of Midie Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Midie Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Midie Xu more than expected).
Fields of papers citing papers by Midie Xu
This network shows the impact of papers produced by Midie Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Midie Xu. The network helps show where Midie Xu may publish in the future.
Co-authorship network of co-authors of Midie Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Midie Xu. A scholar is included among the top collaborators of Midie Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Midie Xu. Midie Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 29 | |
| 7 | 0 | |
| 8 | 50 | |
| 9 | 17 | |
| 10 | 0 | |
| 11 | 101 | |
| 12 | 58 | |
| 13 | 8 | |
| 14 | 42 | |
| 15 | 26 | |
| 16 | MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway | 4 |
| 17 | Clinicopathological features and prognosis of AFP-producing colorectal cancer: a single-center analysis of 20 cases | 4 |
| 18 | 21 | |
| 19 | 30 | |
| 20 | 95 |
About Midie Xu
Midie Xu is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 111 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (19 papers) and Ferroptosis and cancer prognosis (18 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (709 citations) and Molecular Biology (1.6k citations). Midie Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Weiwei Weng, Weiqi Sheng, Cong Tan, Shujuan Ni, Xiang Du, Yong Wu, Dan Huang, Qiongyan Zhang, Ping Wei and Meng Zhang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.